Purexa Global Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 15-11-2024
- Paid Up Capital ₹ 1.25 Cr
as on 15-11-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 14.74%
(FY 2023)
- Profit 24.30%
(FY 2023)
- Ebitda 27.49%
(FY 2023)
- Net Worth -159.69%
(FY 2023)
- Total Assets -10.85%
(FY 2023)
About Purexa Global
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Puneet Kathuria and Sween Kathuria serve as directors at the Company.
- CIN/LLPIN
U52310DL2020PTC361197
- Company No.
361197
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Purexa Global Private Limited offer?
Purexa Global Private Limited offers a wide range of products and services, including Common Disease Medicines, Antiseptic Mouthwashes, Oral Care Products, Hand Sanitizers & Personal Hygiene, Toothpastes, Toothbrush, Ointment.
Who are the key members and board of directors at Purexa Global?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Kathuria  | Director | 31-Jan-2020 | Current |
| Sween Kathuria | Director | 31-Jan-2020 | Current |
Financial Performance of Purexa Global.
Purexa Global Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.74% increase. The company also saw a substantial improvement in profitability, with a 24.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 159.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Purexa Global?
Unlock access to Purexa Global's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
U And K Oral Wellness Limited Liability PartnershipActive 5 years 9 monthsPuneet Kathuria and Sween Kathuria are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Purexa Global?
Unlock and access historical data on people associated with Purexa Global, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Purexa Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purexa Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
